| Niclosamide |
Influence on cell viability |
MTT Assay |
1.00 µM |
HepG2 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
5.00 µM |
HepG2 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
10.00 µM |
HepG2 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
20.00 µM |
HepG2 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell proliferation |
Colony formation assay |
1.00 µM |
HepG2 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell proliferation |
Colony formation assay |
5.00 µM |
HepG2 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell apoptosis |
Flow cytometry- annexin V FITC |
5.00 µM |
HepG2 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell apoptosis |
Hoechst 33342 staining |
5.00 µM |
HepG2 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell apoptosis in presence of cisplatin |
Flow cytometry- annexin V staining |
5.00 µM |
HepG2 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on protein activity |
Western Blot |
5.00 µM |
HepG2 |
Homo sapiens |
|
p-STAT3 |
|
| Niclosamide |
Influence on protein activity |
Western Blot |
5.00 µM |
HepG2 |
Homo sapiens |
|
STAT3 |
|
| Niclosamide |
Influence on protein activity |
Western Blot |
5.00 µM |
HepG2 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on protein activity |
Western Blot |
5.00 µM |
HepG2 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on protein activity |
Western Blot |
5.00 µM |
HepG2 |
Homo sapiens |
|
|
|
